Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · CHIEF EXECUTIVE OFFICER | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 806,111 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 5,361 · Balance 806,111 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1 |
Reported balance
Holding disclosure · report date 2026-09-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1 F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · derivative · entry 16 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403,555 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20 | $43.68 | $873.60 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 14 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 168,598 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 816 | $42.59 | $34,753.44 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 13 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 168,618 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.26 to $43.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,504 | $41.66 | $62,656.64 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 169,434 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.25 to $42.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,660 | $40.62 | $67,429.20 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 170,938 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.24 to $41.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 80 | $43.68 | $3,494.40 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,266 | $42.59 | $139,098.94 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,525 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.26 to $43.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,014 | $41.66 | $250,543.24 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,791 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.25 to $42.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,640 | $40.62 | $269,716.80 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,805 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.24 to $41.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · derivative · entry 15 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,419,555 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 463 | $45.07 | $20,867.41 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 172,598 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.73 to $45.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,537 | $44.10 | $155,981.70 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 173,061 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.72 to $44.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,846 | $45.07 | $83,199.22 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.73 to $45.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 14,154 | $44.10 | $624,191.40 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,291 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.72 to $44.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:09 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-22-028183 · wf-form4_166750612844992.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,910 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · derivative · entry 14 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,435,555 Underlying: Common Stock · 3,910 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 281 | $42.29 | $11,883.49 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 176,598 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.03 to $42.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 596 | $41.27 | $24,596.92 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 176,879 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.02 to $42.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 100 | $40.71 | $4,071.00 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 177,475 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,125 | $42.29 | $47,576.25 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.03 to $42.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 400 | $40.71 | $16,284.00 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,955 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 3,910 | $3.95 | $15,444.50 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · derivative · entry 13 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,439,465 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,385 | $41.27 | $98,428.95 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,570 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.02 to $42.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,213 | $39.99 | $88,497.87 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 177,575 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 to $40.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,787 | $39.51 | $228,644.37 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 179,788 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 to $39.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,846 | $39.99 | $353,751.54 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 to $40.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 23,154 | $39.51 | $914,814.54 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,291 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 to $39.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-22-027227 · wf-form4_166690363398407.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:14 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 2,248 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-026879 · wf-form4_166664237159873.xml · derivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471,465 Underlying: Common Stock · 2,248 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:14 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 562 | $39.38 | $22,131.56 |
DisclosureSEC source: 0001628280-22-026879 · wf-form4_166664237159873.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 185,575 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.36 to $39.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:14 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,248 | $39.38 | $88,526.24 |
DisclosureSEC source: 0001628280-22-026879 · wf-form4_166664237159873.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.36 to $39.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:14 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 2,248 | $3.95 | $8,879.60 |
DisclosureSEC source: 0001628280-22-026879 · wf-form4_166664237159873.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantOption (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $39.39 | $0.00 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · derivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2032-10-18 F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option will vest October 17, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through October 17, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · derivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,473,713 Underlying: Common Stock · 18,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 140 | $40.43 | $5,660.20 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 186,137 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.40 to $40.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,360 | $39.61 | $172,699.60 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 186,277 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.37 to $40.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 560 | $40.43 | $22,640.80 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.40 to $40.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 17,440 | $39.61 | $690,798.40 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,005 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.37 to $40.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 18,000 | $3.95 | $71,100.00 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 400 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · derivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,491,713 Underlying: Common Stock · 400 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 100 | $39.33 | $3,933.00 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 190,637 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 400 | $39.33 | $15,732.00 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 400 | $3.95 | $1,580.00 |
DisclosureSEC source: 0001628280-22-026635 · wf-form4_166621074227576.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 2,160 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,492,113 Underlying: Common Stock · 2,160 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 540 | $39.41 | $21,281.40 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 190,737 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.40 to $39.495, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,160 | $39.41 | $85,125.60 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.40 to $39.495, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 2,160 | $3.95 | $8,532.00 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 240 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,494,273 Underlying: Common Stock · 240 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.